Novum Pharmaceutical Research Services has selected TrialMaster electronic data capture technology from OmniComm Systems, Inc to support their clinical research. Novum with the use of TrialMaster will conduct more than 200 research studies annually due to the flexibility, ease of use, and capabilities that TrialMaster provides.
Read the full release here.
Phase III THARROS Trial to Evaluate Impact of Breztri Aerosphere on Cardiopulmonary Outcomes in COPD
March 14th 2024THARROS trial investigators seek to provide first-of-its-kind evidence supporting a strategy of comprehensive cardiopulmonary risk reduction with a triple therapy in patients with chronic obstructive pulmonary disease.